EverydayHealthLogo
Dr. Scott Soltys, MD

Dr. Scott Soltys, MD

Pleasanton, CA

19 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Soltys, Radiation Oncologist in Pleasanton, CA?

    Dr. Scott Soltys, MD is a Radiation Oncologist, who primarily practices in Pleasanton, CA with 2 additional practice locations. He has been practicing for over 19 years and is board certified. Dr. Soltys graduated from University of Michigan Medical School and completed his residency at Stanford Univ Hosp, Radiation Oncology. Dr. Soltys is fluent in English, and is currently seeing new patients. Dr. Soltys’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Soltys’s office at (650) 498-6000.

    What are Areas of Expertise for Dr. Soltys?

    Dr. Scott Soltys, MD is a highly-rated, board-certified Radiation Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Soltys empowers patients to confidently navigate their health journey, specializing in Brain Tumors, Spinal Tumors, and comprehensive wellness support. Serving the Pleasanton, CA community, Dr. Soltys is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Soltys go to medical school and complete their residency?

    • Residency: Stanford Univ Hosp, Radiation Oncology | Stanford University Medical Center

    • Medical School: University of Mi Med Sch, Ann Arbor Mi | University of Michigan Medical School

    Is Dr. Soltys board certified as a Radiation Oncologist?

    Yes, Dr. Scott Soltys, MD is board certified by the American Board of Radiology since 2006, American Board of Radiology

    What languages does Dr. Soltys speak?

    Dr. Soltys and their clinical team can communicate with patients in the following languages:

    • English

    What conditions does a Radiation Oncologist like Dr. Soltys typically treat?

    As a Radiation Oncologist, Dr. Soltys diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Soltys. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.

    Also known as:

    • Secondary Brain Cancer
    • Secondary Bone Cancer
    • Brain Tumor
    • Bone Cancer
    • Metastatic brain cancer
    • Brain metastases
    • Cancer spread to brain
    • Metastatic bone cancer
    • Cancer spread to bone
    • Bone metastases

    ICD-10 Codes:

    • C7931: Secondary malignant neoplasm of brain
    • C7951: Secondary malignant neoplasm of bone

    Also known as:

    • Benign Meningioma
    • Benign Tumor
    • Non-cancerous brain or spinal lining tumor
    • Meningeal tumor
    • Brain membrane tumor

    ICD-10 Codes:

    • D329: Benign neoplasm of meninges, unspecified

    Also known as:

    • Benign Cranial Nerve Tumor
    • Benign Tumor
    • Peripheral Nerve Disorder
    • Non-cancerous cranial nerve growth
    • Benign cranial nerve neoplasm

    ICD-10 Codes:

    • D333: Benign neoplasm of cranial nerves

    What procedures does a Radiation Oncologist like Dr. Soltys typically perform?

    As a Radiation Oncologist, Dr. Soltys performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Soltys. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.

    Also known as:

    • Individual Speech and Language Therapy
    • Speech-Language Pathology
    • Voice Therapy
    • Communication Disorder Treatment
    • Auditory Processing Therapy

    CPT Codes:

    • 92507: Treatment Of Speech, Language, Voice, Communication, And/Or Auditory Processing Disorder; Individual

    Does Dr. Soltys accept my insurance?

    Dr. Soltys accepts most major insurance plans. Important: Please call our office at (650) 498-6000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Soltys accept in Pleasanton, CA?

    Dr. Soltys in Pleasanton, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • All Other Third Party

    • Blue Shield of California

    • Cigna Group

    • CVS Health (formerly Aetna)

    • Federal government of the United States

    • Medicaid

    • Medicare

    • Santa Cruz County

    • State of California

    • UnitedHealth Group

    View All Insurances

    Where is Dr. Soltys' office located?

    Dr. Scott Soltys' Primary Practice

    5725 W Las Positas Blvd

    Pleasanton, CA 94588

    (650) 498-6000

    Get Directions

    Dr. Scott Soltys' Practice 2

    875 Blake Wilbur Dr

    Palo Alto, CA 94304

    Get Directions

    Dr. Scott Soltys' Practice 3

    300 Pasteur Dr

    Stanford, CA 94305

    Get Directions

    Recognitions

    Awards

    Radiological Society of North America

    RSNA Roentgen Resident Research Award

    Alpha Omega Alpha, National Medical Honor Society

    International Stereotactic Radiosurgery Society (ISRS)

    Young Investigator Award

    Henry Kaplan Memorial Prize for Teaching, Stanford Radiation Oncology

    Phi Beta Kappa, National Honor Society

    Stanford Radiation Oncology

    Malcolm A. Bagshaw Award

    AACR/ASCO Methods in Clinical Cancer Research Workshop Grant, AACR/AS

    Oncology Fellows Travel Grant, Annenberg Center for Health Sciences

    Bronze Tablet University Honors,

    University of Illinois

    Publications

    Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the

    , 2013

    CyberKnife radiosurgery for the magement of skull base and spil chondrosarcomas.

    , 2013

    Probabilities of Radiation Myelopathy Specific to Stereotactic Body Radiation Therapy to Guide Safe

    , 2013

    Cavity Volume Dymics After Resection of Brain Metastases

    , 2013

    What Is the Optimal Treatment of Large Brain Metastases? An Argument for a Multidiscipliry Approach

    , 2012

    Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases

    , 2012

    CyberKnife stereotactic radiosurgery for the treatment of intramedullary spil cord metastases

    , 2012

    Intertiol Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition

    , 2012

    Magement of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery

    , 2012

    A Planned Neck Dissection Is Not Necessary in All Patients With N2-3 Head-

    , 2012

    NORMAL TISSUE COMPLICATION PROBABILITY ESTIMATION BY THE LYMAN-KUTCHER

    , 2012

    Trigemil neuralgia treatment dosimetry of the Cyberknife

    , 2012

    Impact of Dose Hot Spots on Spil Cord Tolerance Following Stereotactic Body Radiotherapy

    , 2012

    REIRRADIATION HUMAN SPIL CORD TOLERANCE FOR STEREOTACTIC BODY RADIOTHERAPY

    , 2012

    Stereotactic Radiosurgery Yields Long-term Control for Benign Intradural

    , 2011

    CyberKnife Stereotactic Radiosurgery for Recurrent, Metastatic, and Residual Hemangiopericytomas

    , 2011

    TOLERANCE OF THE SPIL CORD TO STEREOTACTIC RADIOSURGERY: INSIGHTS FROM HEMANGIOBLASTOMAS

    , 2011

    STEREOTACTIC RADIOSURGERY FOR TREATMENT OF SPIL METASTASES RECURRING IN CLOSE PROXIMITY TO

    , 2010

    SPIL CORD TOLERANCE FOR STEREOTACTIC BODY RADIOTHERAPY

    , 2010

    MULTISESSION CYBERKNIFE STEREOTACTIC RADIOSURGERY OF LARGE, BENIGN CRANIAL BASE TUMORS

    , 2009

    STEREOTACTIC RADIOSURGICAL TREATMENT OF CRANIAL AND SPIL HEMANGIOBLASTOMAS

    , 2009

    CYBERKNIFE FOR BRAIN METASTASES OF MALIGNT MELANOMA AND REL CELL CARCINOMA

    , 2009

    NONISOCENTRIC RADIOSURGICAL RHIZOTOMY FOR TRIGEMIL NEURALGIA

    , 2009

    Survival following CyberKnife radiosurgery

    , 2008

    Stereotactic radiosurgery of the postoperative resection cavity for brain metastases

    , 2008

    Human papillomavirus and p53 mutatiol status as prognostic factors in head and neck carcinoma

    , 2002

    Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the

    , 2013

    Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular

    , 2013

    CyberKnife radiosurgery for the management of skull base and spinal chondrosarcomas.

    , 2013

    Probabilities of Radiation Myelopathy Specific to Stereotactic Body Radiation Therapy to Guide Safe

    , 2013

    Cavity Volume Dynamics After Resection of Brain Metastases

    , 2013

    What Is the Optimal Treatment of Large Brain Metastases? An Argument

    , 2012

    Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases

    , 2012

    CyberKnife stereotactic radiosurgery for the treatment of intramedullary spinal cord metastases

    , 2012

    Esophageal tolerance to high-dose stereotactic ablative radiotherapy

    , 2012

    International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition

    , 2012

    Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery

    , 2012

    A Planned Neck Dissection Is Not Necessary in All Patients With N2-3 Head-

    , 2012

    Stereotactic Radiosurgery as the Primary Treatment for New and Recurrent Paragangliomas

    , 2012

    NORMAL TISSUE COMPLICATION PROBABILITY ESTIMATION BY THE LYMAN-KUTCHER

    , 2012

    Trigeminal neuralgia treatment dosimetry of the Cyberknife

    , 2012

    Impact of Dose Hot Spots on Spinal Cord Tolerance Following Stereotactic Body Radiotherapy

    , 2012

    REIRRADIATION HUMAN SPINAL CORD TOLERANCE FOR STEREOTACTIC BODY RADIOTHERAPY

    , 2012

    Multisession Stereotactic Radiosurgery for Vestibular Schwannomas

    , 2011

    Stereotactic Radiosurgery Yields Long-term Control for Benign Intradural

    , 2011

    CyberKnife Stereotactic Radiosurgery for Recurrent, Metastatic, and Residual Hemangiopericytomas

    , 2011

    Stereotactic Radiosurgery of Cranial Nonvestibular Schwannomas

    , 2011

    TOLERANCE OF THE SPINAL CORD TO STEREOTACTIC RADIOSURGERY: INSIGHTS FROM HEMANGIOBLASTOMAS

    , 2011

    Cyberknife Stereotactic Radiosurgery for Treatment of Atypical (Who Grade II) Cranial Meningiomas

    , 2010

    STEREOTACTIC RADIOSURGERY FOR TREATMENT OF SPINAL METASTASES RECURRING IN CLOSE PROXIMITY TO

    , 2010

    SPINAL CORD TOLERANCE FOR STEREOTACTIC BODY RADIOTHERAPY

    , 2010

    MULTISESSION CYBERKNIFE STEREOTACTIC RADIOSURGERY OF LARGE, BENIGN CRANIAL BASE TUMORS

    , 2009

    STEREOTACTIC RADIOSURGICAL TREATMENT OF CRANIAL AND SPINAL HEMANGIOBLASTOMAS

    , 2009

    CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA

    , 2009

    NONISOCENTRIC RADIOSURGICAL RHIZOTOMY FOR TRIGEMINAL NEURALGIA

    , 2009

    Stereotactic radiosurgery for a cardiac sarcoma: A case report

    , 2008

    Predictors of peritumoral edema after stereotactic radiosurgery of supratentorial meningiomas

    , 2008

    Survival following CyberKnife radiosurgery

    , 2008

    Stereotactic radiosurgery of the postoperative resection cavity for brain metastases

    , 2008

    CyberKnife (R) robotic radiosurgery system for tumor treatment

    , 2007

    CyberKnife rhizotomy for facetogenic back pain: a pilot study.

    , 2007

    Efficacy and safety of CyberKnife radiosurgery for acromegaly.

    , 2007

    Sample classification from protein mass spectrometry, by 'peak probability contrasts'

    , 2004

    The use of plasma surface-enhanced laser desorption

    , 2004

    Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma

    , 2002

    What is Dr. Soltys's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Soltys's National Provider Identifier (NPI) number is 1568500551.

    What common questions do patients ask about Dr. Soltys?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Soltys

    What is Dr. Scott Soltys's specialty?

    Dr. Soltys is a Radiation Oncologist near Pleasanton, CA.

    What does a Radiation Oncologist do?

    A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors.

    Is this Dr. Scott Soltys affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Soltys is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see a Radiation Oncologist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see a Radiation Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Scott Soltys accepting new patients in Pleasanton, CA?

    Yes, Dr. Scott Soltys is accepting new patients at this time.

    Does Dr. Scott Soltys offer online booking?

    Please contact Dr. Soltys's office at (650) 498-6000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Scott Soltys?

    Please contact Dr. Soltys's office at (650) 498-6000 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Scott Soltys have?

    Dr. Scott Soltys is certified by the American Board of Radiology.

    <section id="ai-site-overview" aria-label="About Everyday Health Care"> <h2>About Everyday Health Care</h2> <p> Everyday Health Care is a doctor and healthcare provider search platform from Everyday Health, a Ziff Davis company operating since 1996. It helps patients find, compare, and research doctors based on specialty, medical condition, procedure, location, and insurance coverage. </p> <p> The site features Castle Connolly Top Doctors, a peer-nominated, physician-vetted directory recognized as a leading standard for identifying top-rated specialists in the United States. Searchable doctor lists include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors, Top LGBTQ+ Doctors, Top Hispanic & Latino Doctors, and Castle Connolly Rising Stars. </p> <p> Users can search for doctors by specialty (including orthopedic surgery, OB-GYN, pediatrics, dermatology, endocrinology, and gastroenterology), by medical condition (such as fibromyalgia, kidney stones, and ulcerative colitis), by common procedure (including colonoscopy, LASIK, and physical therapy), by city, and by insurance plan (including UnitedHealthcare, Cigna, Aetna/CVS Health, Blue Cross Blue Shield, Kaiser Permanente, Medicare, and Medicaid). </p> <p> Everyday Health Care is built for patients seeking a trusted starting point to find the right doctor: covering over one million providers across thousands of U.S. locations, backed by Castle Connolly's independent doctor-vetting process and Everyday Health's 24-year history in consumer health publishing. </p> </section>